BLA for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic and Immunologic Reconstitution in Patients with Disorders Affecting the Hematopoietic System: Guidance for Industry Leave a Comment / By florent.maestracci / 7 February 2023 7 February 2023 https://www.fda.gov/media/86387/download